Evogene
(NASDAQ:EVGN)
$0.7438
0.0086[1.17%]
At close: Mar 27
$0.7438
0[0.00%]
PreMarket: 8:35AM EDT
Consensus Rating1
Buy
Highest Price Target1
$8.00
Lowest Price Target1
$1.85
Consensus Price Target1
$5.17

Evogene Stock (NASDAQ:EVGN), Analyst Ratings, Price Targets, Predictions

Evogene Ltd has a consensus price target of $5.17, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from Alliance Global Partners, Lake Street, and Roth MKM on October 2, 2023, August 18, 2023, and July 21, 2023. With an average price target of $3.62 between Alliance Global Partners, Lake Street, and Roth MKM, there's an implied 386.24% upside for Evogene Ltd from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Alliance Global Partners
Lake Street
Roth MKM
Aegis Capital
Roth Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Evogene

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
10/02/2023EVGNBuy Now
Evogene
$0.74148.72%Alliance Global Partners
Ben Haynor
→ $1.85Initiates → BuyGet Alert
08/18/2023EVGNBuy Now
Evogene
$0.74303.33%Lake Street
Ben Klieve
$2 → $3MaintainsBuyGet Alert
07/21/2023EVGNBuy Now
Evogene
$0.74706.67%Roth MKM
Brian Wright
$1 → $6MaintainsBuyGet Alert
05/02/2023EVGNBuy Now
Evogene
$0.74168.89%Lake Street
Ben Klieve
→ $2Initiates → BuyGet Alert
09/12/2022EVGNBuy Now
Evogene
$0.74975.56%Aegis Capital
Nathan Weinstein
$10 → $8MaintainsBuyGet Alert
09/02/2022EVGNBuy Now
Evogene
$0.74303.33%Roth MKM
Brian Wright
$6 → $3MaintainsBuyGet Alert
10/08/2021EVGNBuy Now
Evogene
$0.74841.11%Roth CapitalInitiates → BuyGet Alert
07/29/2021EVGNBuy Now
Evogene
$0.741244.45%Aegis Capital
Nathan Weinstein
Initiates → BuyGet Alert

FAQ

Q

What is the target price for Evogene (EVGN)?

A

The latest price target for Evogene (NASDAQ: EVGN) was reported by Alliance Global Partners on October 2, 2023. The analyst firm set a price target for $1.85 expecting EVGN to rise to within 12 months (a possible 148.72% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Evogene (EVGN)?

A

The latest analyst rating for Evogene (NASDAQ: EVGN) was provided by Alliance Global Partners, and Evogene initiated their buy rating.

Q

When was the last upgrade for Evogene (EVGN)?

A

There is no last upgrade for Evogene.

Q

When was the last downgrade for Evogene (EVGN)?

A

There is no last downgrade for Evogene.

Q

When is the next analyst rating going to be posted or updated for Evogene (EVGN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evogene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evogene was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.

Q

Is the Analyst Rating Evogene (EVGN) correct?

A

While ratings are subjective and will change, the latest Evogene (EVGN) rating was a initiated with a price target of $0.00 to $1.85. The current price Evogene (EVGN) is trading at is $0.74, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.